bluuebunny/crossref_metadata_2025 huggingface dataset:
Table S2 from TIGIT Expression Is Associated with T-cell Suppression and Exhaustion and Predicts Clinical Outcome and Anti–PD-1 Response in Follicular Lymphoma
Authors: Yang Zhi-Zhang , Kim Hyo Jin , Wu Hongyan , Jalali Shahrzad , Tang Xinyi , Krull Jordan E. , Ding Wei , Novak Anne J. , Ansell Stephen M.
Published: April 2023

CyTOF staining panel
Figure S1 from NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes
Authors: Singh Anju , Daemen Anneleen , Nickles Dorothee , Jeon Sang-Min , Foreman Oded , Sudini Kuladeep , Gnad Florian , Lajoie Stephane , Gour Naina , Mitzner Wayne , Chatterjee Samit , Choi Eun-Ji , Ravishankar Buvana , Rappaport Amy , Patil Namrata , McCleland Mark , Johnson Leisa , Acquaah-Mensah George , Gabrielson Edward , Biswal Shyam , Hatzivassiliou Georgia
Published: April 2023

Fig. S1, related to Figs 1 & 2. Tumor histology across genotypes at 8-16 weeks after Adeno-Cre infection.
Supplementary Figure legends from TIGIT Expression Is Associated with T-cell Suppression and Exhaustion and Predicts Clinical Outcome and Anti–PD-1 Response in Follicular Lymphoma
Authors: Yang Zhi-Zhang , Kim Hyo Jin , Wu Hongyan , Jalali Shahrzad , Tang Xinyi , Krull Jordan E. , Ding Wei , Novak Anne J. , Ansell Stephen M.
Published: April 2023

Texts for supplementary figure legends
Supplementary Table S4 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Authors: Arena Sabrina , Corti Giorgio , Durinikova Erika , Montone Monica , Reilly Nicole M. , Russo Mariangela , Lorenzato Annalisa , Arcella Pamela , Lazzari Luca , Rospo Giuseppe , Pagani Massimiliano , Cancelliere Carlotta , Negrino Carola , Isella Claudio , Bartolini Alice , Cassingena Andrea , Amatu Alessio , Mauri Gianluca , Sartore-Bianchi Andrea , Mittica Gloria , Medico Enzo , Marsoni Silvia , Linnebacher Michael , Abrignani Sergio , Siena Salvatore , Di Nicolantonio Federica , Bardelli Alberto
Published: April 2023

Supplementary Table S4
Supplementary Table S3 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Authors: Arena Sabrina , Corti Giorgio , Durinikova Erika , Montone Monica , Reilly Nicole M. , Russo Mariangela , Lorenzato Annalisa , Arcella Pamela , Lazzari Luca , Rospo Giuseppe , Pagani Massimiliano , Cancelliere Carlotta , Negrino Carola , Isella Claudio , Bartolini Alice , Cassingena Andrea , Amatu Alessio , Mauri Gianluca , Sartore-Bianchi Andrea , Mittica Gloria , Medico Enzo , Marsoni Silvia , Linnebacher Michael , Abrignani Sergio , Siena Salvatore , Di Nicolantonio Federica , Bardelli Alberto
Published: April 2023

Supplementary Table S3
Supplementary Table S2 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Authors: Arena Sabrina , Corti Giorgio , Durinikova Erika , Montone Monica , Reilly Nicole M. , Russo Mariangela , Lorenzato Annalisa , Arcella Pamela , Lazzari Luca , Rospo Giuseppe , Pagani Massimiliano , Cancelliere Carlotta , Negrino Carola , Isella Claudio , Bartolini Alice , Cassingena Andrea , Amatu Alessio , Mauri Gianluca , Sartore-Bianchi Andrea , Mittica Gloria , Medico Enzo , Marsoni Silvia , Linnebacher Michael , Abrignani Sergio , Siena Salvatore , Di Nicolantonio Federica , Bardelli Alberto
Published: April 2023

Supplementary Table S2
Supplementary Table 1 from A Performance Comparison of Commonly Used Assays to Detect RET Fusions
Authors: Yang Soo-Ryum , Aypar Umut , Rosen Ezra Y. , Mata Douglas A. , Benayed Ryma , Mullaney Kerry , Jayakumaran Gowtham , Zhang Yanming , Frosina Denise , Drilon Alexander , Ladanyi Marc , Jungbluth Achim A. , Rekhtman Natasha , Hechtman Jaclyn F.
Published: April 2023

Supplementary Table 1: (A) Full clinical and pathologic data. (B) DNA and RNA sequencing data. (C) Plasma cell-free DNA data. (D) Break-apart FISH. (E) Immunohistochemistry.
Supplementary Methods from A Performance Comparison of Commonly Used Assays to Detect RET Fusions
Authors: Yang Soo-Ryum , Aypar Umut , Rosen Ezra Y. , Mata Douglas A. , Benayed Ryma , Mullaney Kerry , Jayakumaran Gowtham , Zhang Yanming , Frosina Denise , Drilon Alexander , Ladanyi Marc , Jungbluth Achim A. , Rekhtman Natasha , Hechtman Jaclyn F.
Published: April 2023

Supplementary Methods for FISH and immunohistochemistry.
Tables S1-S8 from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
Authors: Makohon-Moore Alvin P. , Lipson Evan J. , Hooper Jody E. , Zucker Amanda , Hong Jungeui , Bielski Craig M. , Hayashi Akimasa , Tokheim Collin , Baez Priscilla , Kappagantula Rajya , Kohutek Zachary , Makarov Vladimir , Riaz Nadeem , Postow Michael A. , Chapman Paul B. , Karchin Rachel , Socci Nicholas D. , Solit David B. , Chan Timothy A. , Taylor Barry S. , Topalian Suzanne L. , Iacobuzio-Donahue Christine A.
Published: April 2023

Supplementary Tables S1-S8 show the samples used for study (Table S1), the somatic single nucleotide variants, small insertions and small deletions (Table S2), the somatic copy number alterations anallyzed (Table S3), the gene list used to analyze somatic mutations (Table S4), putative driver genes, immunotherapy related genes, and mutation-targeted therapy genes affected by mutations in each case (Table S5), mutation signatures detected with a cosine score {greater than or equal to}0.80 (Table S6), Jaccard similarity coefficients (Table S7), and putative neoantigens in each case (Table S8).
Supplemental Table 2 from Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
Authors: Aggen David H. , Ager Casey R. , Obradovic Aleksandar Z. , Chowdhury Nivedita , Ghasemzadeh Ali , Mao Wendy , Chaimowitz Matthew G. , Lopez-Bujanda Zoila A. , Spina Catherine S. , Hawley Jessica E. , Dallos Matthew C. , Zhang Cheng , Wang Vinson , Li Hu , Guo Xinzheng V. , Drake Charles G.
Published: April 2023

Antibodies used for multi-parameter immune profiling using Cytek Aurora
Supplemental Figure 9 from Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
Authors: Aggen David H. , Ager Casey R. , Obradovic Aleksandar Z. , Chowdhury Nivedita , Ghasemzadeh Ali , Mao Wendy , Chaimowitz Matthew G. , Lopez-Bujanda Zoila A. , Spina Catherine S. , Hawley Jessica E. , Dallos Matthew C. , Zhang Cheng , Wang Vinson , Li Hu , Guo Xinzheng V. , Drake Charles G.
Published: April 2023

Assessment of TME changes in MC38 tumors with combination cabozantinib and anti-interleukin-1b immunotherapy.
Figure S2 from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
Authors: Makohon-Moore Alvin P. , Lipson Evan J. , Hooper Jody E. , Zucker Amanda , Hong Jungeui , Bielski Craig M. , Hayashi Akimasa , Tokheim Collin , Baez Priscilla , Kappagantula Rajya , Kohutek Zachary , Makarov Vladimir , Riaz Nadeem , Postow Michael A. , Chapman Paul B. , Karchin Rachel , Socci Nicholas D. , Solit David B. , Chan Timothy A. , Taylor Barry S. , Topalian Suzanne L. , Iacobuzio-Donahue Christine A.
Published: April 2023

Figure S2 shows the pattern of C>T mutations at dipyrimidines and nondipyrimidines.
Supplemental Figure 7 from Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
Authors: Aggen David H. , Ager Casey R. , Obradovic Aleksandar Z. , Chowdhury Nivedita , Ghasemzadeh Ali , Mao Wendy , Chaimowitz Matthew G. , Lopez-Bujanda Zoila A. , Spina Catherine S. , Hawley Jessica E. , Dallos Matthew C. , Zhang Cheng , Wang Vinson , Li Hu , Guo Xinzheng V. , Drake Charles G.
Published: April 2023

Top 30 immune genes from Nanonstring I/O 360 gene list for clusters 1, 4, 8, and 12.
Figure S1 from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
Authors: Makohon-Moore Alvin P. , Lipson Evan J. , Hooper Jody E. , Zucker Amanda , Hong Jungeui , Bielski Craig M. , Hayashi Akimasa , Tokheim Collin , Baez Priscilla , Kappagantula Rajya , Kohutek Zachary , Makarov Vladimir , Riaz Nadeem , Postow Michael A. , Chapman Paul B. , Karchin Rachel , Socci Nicholas D. , Solit David B. , Chan Timothy A. , Taylor Barry S. , Topalian Suzanne L. , Iacobuzio-Donahue Christine A.
Published: April 2023

Figure S1 shows sequencing results, somatic copy number, and whole genome duplication analysis.
Supplementary Tables from Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia
Authors: Lin Xiaojing , Qiao Niu , Shen Yang , Fang Hai , Xue Qing , Cui Bowen , Chen Li , Zhu Hongming , Zhang Sujiang , Chen Yu , Jiang Lu , Wang Shengyue , Li Junmin , Wang Bingshun , Chen Bing , Chen Zhu , Chen Saijuan
Published: April 2023

Supplementary Table S1-S26
Supplemental Figure 10 from Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
Authors: Aggen David H. , Ager Casey R. , Obradovic Aleksandar Z. , Chowdhury Nivedita , Ghasemzadeh Ali , Mao Wendy , Chaimowitz Matthew G. , Lopez-Bujanda Zoila A. , Spina Catherine S. , Hawley Jessica E. , Dallos Matthew C. , Zhang Cheng , Wang Vinson , Li Hu , Guo Xinzheng V. , Drake Charles G.
Published: April 2023

Overall survival for metastatic RCC patients based on IL-1beta expression.
Figure S6 from Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia
Authors: Lin Xiaojing , Qiao Niu , Shen Yang , Fang Hai , Xue Qing , Cui Bowen , Chen Li , Zhu Hongming , Zhang Sujiang , Chen Yu , Jiang Lu , Wang Shengyue , Li Junmin , Wang Bingshun , Chen Bing , Chen Zhu , Chen Saijuan
Published: April 2023

Figure S6. GSEA plots of functional categories between 34 high- and 27 low-risk patients with APL. GSEA plots of the megakaryocyte differentiation (A), angiogenesis (B), coagulation (C), erythrocyte differentiation (D), erythrocyte development (E), inflammatory response (F), complement (G), and chemokine activity (H) in 34 high- and 27 low-risk patients with APL. GSEA, Gene set enrichment analysis; NES, normalized enrichment score.
Supplementary Table 3 from Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
Authors: Gao ChongFeng , Wisniewski Luke , Liu Ying , Staal Ben , Beddows Ian , Plenker Dennis , Aldakkak Mohammed , Hall Johnathan , Barnett Daniel , Gouda Mirna Kheir , Allen Peter , Drake Richard , Zureikat Amer , Huang Ying , Evans Douglas , Singhi Aatur , Brand Randall E. , Tuveson David A. , Tsai Susan , Haab Brian B.
Published: April 2023

Plasma-biomarker analyses
Supplementary Tables S1-S11 from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Authors: Hitchman Tyler D. , Bayshtok Gabriella , Ceraudo Emilie , Moore Amanda R. , Lee Cindy , Jia Ruobing , Wang Naitao , Pachai Mohini R. , Shoushtari Alexander N. , Francis Jasmine H. , Guan Youxin , Chen Juliet , Chang Matthew T. , Taylor Barry S. , Sakmar Thomas P. , Huber Thomas , Chi Ping , Chen Yu
Published: April 2023

List of Primers, antibodies, genesets, rna-seq geneset overlaps used in our study.
Figure S14 from Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia
Authors: Lin Xiaojing , Qiao Niu , Shen Yang , Fang Hai , Xue Qing , Cui Bowen , Chen Li , Zhu Hongming , Zhang Sujiang , Chen Yu , Jiang Lu , Wang Shengyue , Li Junmin , Wang Bingshun , Chen Bing , Chen Zhu , Chen Saijuan
Published: April 2023

Figure S14. The revised risk groups are associated with survivals in patients with APL. (A) Kaplan-Meier estimates of OS, EFS, and DFS of the patients from Sanz low-to-intermediate risk crossed to the revised HR group (n = 9 with both NRAS mutation and high APL9 score group) and the patients from Sanz low-to-intermediate risk remaining in the revised SR group (n = 210). (B) Kaplan-Meier estimates of OS, EFS, and DFS of the patients from Sanz high-risk crossed to the revised SR group (n = 18 with neither NRAS mutation nor high APL9 score group) and the patients from Sanz high-risk remaining in the revised HR group (n = 86). P-value is calculated using the log-rank test. OS, overall survival; EFS, event-free survival; DFS, disease-free survival; HR, high-risk; SR, standard-risk
Supplementary Table S5 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Authors: Parikh Aparna R. , Mojtahed Amikasra , Schneider Jaime L. , Kanter Katie , Van Seventer Emily E. , Fetter Isobel J. , Thabet Ashraf , Fish Madeleine G. , Teshome Bezaye , Fosbenner Kathryn , Nadres Brandon , Shahzade Heather A. , Allen Jill N. , Blaszkowsky Lawrence S. , Ryan David P. , Giantonio Bruce , Goyal Lipika , Nipp Ryan D. , Roeland Eric , Weekes Colin D. , Wo Jennifer Y. , Zhu Andrew X. , Dias-Santagata Dora , Iafrate A. John , Lennerz Jochen K. , Hong Theodore S. , Siravegna Giulia , Horick Nora , Clark Jeffrey W. , Corcoran Ryan B.
Published: April 2023

Supplementary Table S5
Supplementary Table S1 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Authors: Parikh Aparna R. , Mojtahed Amikasra , Schneider Jaime L. , Kanter Katie , Van Seventer Emily E. , Fetter Isobel J. , Thabet Ashraf , Fish Madeleine G. , Teshome Bezaye , Fosbenner Kathryn , Nadres Brandon , Shahzade Heather A. , Allen Jill N. , Blaszkowsky Lawrence S. , Ryan David P. , Giantonio Bruce , Goyal Lipika , Nipp Ryan D. , Roeland Eric , Weekes Colin D. , Wo Jennifer Y. , Zhu Andrew X. , Dias-Santagata Dora , Iafrate A. John , Lennerz Jochen K. , Hong Theodore S. , Siravegna Giulia , Horick Nora , Clark Jeffrey W. , Corcoran Ryan B.
Published: April 2023

Supplementary Table S1
Supplementary Table S2 from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions
Authors: Rickelt Steffen , Condon Charlene , Mana Miyeko , Whittaker Charlie , Pfirschke Christina , Roper Jatin , Patil Deepa T. , Brown Ian , Mattia Anthony R. , Zukerberg Lawrence , Zhao Qing , Chetty Runjan , Lauwers Gregory Y. , Neyaz Azfar , Leijssen Lieve G.J. , Boylan Katherine , Yilmaz Omer H. , Deshpande Vikram , Hynes Richard O.
Published: April 2023

Sample information and results.
Supplementary Table S1 from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions
Authors: Rickelt Steffen , Condon Charlene , Mana Miyeko , Whittaker Charlie , Pfirschke Christina , Roper Jatin , Patil Deepa T. , Brown Ian , Mattia Anthony R. , Zukerberg Lawrence , Zhao Qing , Chetty Runjan , Lauwers Gregory Y. , Neyaz Azfar , Leijssen Lieve G.J. , Boylan Katherine , Yilmaz Omer H. , Deshpande Vikram , Hynes Richard O.
Published: April 2023

Differential expression data.
Supplementary Figure S6 from Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Authors: Chen Jingwei , Nelson Christopher , Wong Matthew , Tee Andrew E. , Liu Pei Y. , La Ting , Fletcher Jamie I. , Kamili Alvin , Mayoh Chelsea , Bartenhagen Christoph , Trahair Toby N. , Xu Ning , Jayatilleke Nisitha , Wong Marie , Peng Hui , Atmadibrata Bernard , Cheung Belamy B. , Lan Qing , Bryan Tracy M. , Mestdagh Pieter , Vandesompele Jo , Combaret Valerie , Boeva Valentina , Wang Jenny Y. , Janoueix-Lerosey Isabelle , Cowley Mark J. , MacKenzie Karen L. , Dolnikov Alla , Li Jinyan , Polly Patsie , Marshall Glenn M. , Reddel Roger R. , Norris Murray D. , Haber Michelle , Fischer Matthias , Zhang Xu D. , Pickett Hilda A. , Liu Tao
Published: April 2023

Supplementary Figure S6. OTX015 and carfilzomib exert synergistic anticancer effects partly by inducing oxidative stress and endoplasmic reticulum stress.
Supplementary Figure S6 from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions
Authors: Rickelt Steffen , Condon Charlene , Mana Miyeko , Whittaker Charlie , Pfirschke Christina , Roper Jatin , Patil Deepa T. , Brown Ian , Mattia Anthony R. , Zukerberg Lawrence , Zhao Qing , Chetty Runjan , Lauwers Gregory Y. , Neyaz Azfar , Leijssen Lieve G.J. , Boylan Katherine , Yilmaz Omer H. , Deshpande Vikram , Hynes Richard O.
Published: April 2023

AGRN staining in SSL samples of serrated polyposis syndrome patients.
Supplementary Figure S3 from Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Authors: Chen Jingwei , Nelson Christopher , Wong Matthew , Tee Andrew E. , Liu Pei Y. , La Ting , Fletcher Jamie I. , Kamili Alvin , Mayoh Chelsea , Bartenhagen Christoph , Trahair Toby N. , Xu Ning , Jayatilleke Nisitha , Wong Marie , Peng Hui , Atmadibrata Bernard , Cheung Belamy B. , Lan Qing , Bryan Tracy M. , Mestdagh Pieter , Vandesompele Jo , Combaret Valerie , Boeva Valentina , Wang Jenny Y. , Janoueix-Lerosey Isabelle , Cowley Mark J. , MacKenzie Karen L. , Dolnikov Alla , Li Jinyan , Polly Patsie , Marshall Glenn M. , Reddel Roger R. , Norris Murray D. , Haber Michelle , Fischer Matthias , Zhang Xu D. , Pickett Hilda A. , Liu Tao
Published: April 2023

Supplementary Figure S3. Screening for Approved Oncology Drugs (AODs) exerting synergistic anticancer effects with BET bromodomain inhibitors against TERT-rearranged neuroblastoma cells.
Supplementary Figure S2 from Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Authors: Chen Jingwei , Nelson Christopher , Wong Matthew , Tee Andrew E. , Liu Pei Y. , La Ting , Fletcher Jamie I. , Kamili Alvin , Mayoh Chelsea , Bartenhagen Christoph , Trahair Toby N. , Xu Ning , Jayatilleke Nisitha , Wong Marie , Peng Hui , Atmadibrata Bernard , Cheung Belamy B. , Lan Qing , Bryan Tracy M. , Mestdagh Pieter , Vandesompele Jo , Combaret Valerie , Boeva Valentina , Wang Jenny Y. , Janoueix-Lerosey Isabelle , Cowley Mark J. , MacKenzie Karen L. , Dolnikov Alla , Li Jinyan , Polly Patsie , Marshall Glenn M. , Reddel Roger R. , Norris Murray D. , Haber Michelle , Fischer Matthias , Zhang Xu D. , Pickett Hilda A. , Liu Tao
Published: April 2023

Supplementary Figure S2. BRD4 is required for TERT expression and cell proliferation in TERT-rearranged neuroblastoma cells.
Supplementary Figure S2 from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions
Authors: Rickelt Steffen , Condon Charlene , Mana Miyeko , Whittaker Charlie , Pfirschke Christina , Roper Jatin , Patil Deepa T. , Brown Ian , Mattia Anthony R. , Zukerberg Lawrence , Zhao Qing , Chetty Runjan , Lauwers Gregory Y. , Neyaz Azfar , Leijssen Lieve G.J. , Boylan Katherine , Yilmaz Omer H. , Deshpande Vikram , Hynes Richard O.
Published: April 2023

Initial immunohistochemical validation and patient sample summary.
Supplementary Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
Authors: Hegde Aparna , Jayaprakash Priyamvada , Couillault Coline A. , Piha-Paul Sarina , Karp Daniel , Rodon Jordi , Pant Shubham , Fu Siqing , Dumbrava Ecaterina E. , Yap Timothy A. , Subbiah Vivek , Bhosale Priya , Coarfa Cristian , Higgins Jack P. , Williams Eric T. , Wilson Thomas F. , Lim JoAnn , Meric-Bernstam Funda , Sumner Elizabeth , Zain Hira , Nguyen Di , Nguyen Ly M. , Rajapakshe Kimal , Curran Michael A. , Hong David S.
Published: April 2023

Compilation of supplemental tables and figures
Supplementary Documents from Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions
Authors: Rickelt Steffen , Condon Charlene , Mana Miyeko , Whittaker Charlie , Pfirschke Christina , Roper Jatin , Patil Deepa T. , Brown Ian , Mattia Anthony R. , Zukerberg Lawrence , Zhao Qing , Chetty Runjan , Lauwers Gregory Y. , Neyaz Azfar , Leijssen Lieve G.J. , Boylan Katherine , Yilmaz Omer H. , Deshpande Vikram , Hynes Richard O.
Published: April 2023

File contains: Supplementary Materials and Methods, Supplementary Figure Legends and Supplementary References
Supplementary table 2 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
Authors: Thakur Shilpa , Daley Brianna , Millo Corina , Cochran Craig , Jacobson Orit , Lu Huiyan , Wang Zhantong , Kiesewetter Dale , Chen Xiaoyuan , Vasko Vasyl , Klubo-Gwiezdzinska Joanna
Published: April 2023

Supplemental Table 2. Analysis of the metastatic lesions characterized by the highest 68Ga-DOTATATE maximum standard uptake values (SUVmax) in 25 patients enrolled in the clinical trial. The data on patients with SUVmax in metastatic lesions exceeding 15 are bolded. PTC - papillary thyroid cancer, PTCTC - tall cell variant PTC, HTC - Hurthle cell thyroid cancer, MTC - medullary thyroid cancer. * uptake similar to background uptake
Supplementary Figure 7 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
Authors: Thakur Shilpa , Daley Brianna , Millo Corina , Cochran Craig , Jacobson Orit , Lu Huiyan , Wang Zhantong , Kiesewetter Dale , Chen Xiaoyuan , Vasko Vasyl , Klubo-Gwiezdzinska Joanna
Published: April 2023

Supplemental Figure 7: VAC treatment did not improve therapeutic efficacy of DOTA-EB-TATE in either low- or high-SSTR2 expressing tumors. (A) No effect of VAC on the tumor progression in the 177Lu-DOTA-EB-TATE treated FTC133 (low-SSTR2-expressing) subcutaneous xenograft mice model. C-control mice that received 177Lu-DOTA-EB-TATE (n=8); VAC-valproic acid treated mice that received 177Lu-DOTA-EB-TATE (n=9). Data are presented as mean{plus minus}SEM. (B) No effect of VAC on the tumor progression in the 177Lu-DOTA-EB-TATE treated AR42J (high-SSTR2-expressing) subcutaneous xenograft mice model. C-control mice that received 177Lu-DOTA-EB-TATE (n=8); VAC-valproic acid treated mice that received 177Lu-DOTA-EB-TATE (n=7). Data are presented as mean{plus minus}SEM.
Supplementary Table 2 from Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
Authors: Jiffry Jeeshan , Thavornwatanayong Thongthai , Rao Devika , Fogel Elisha J. , Saytoo Durvanand , Nahata Rishika , Guzik Hillary , Chaudhary Imran , Augustine Titto , Goel Sanjay , Maitra Radhashree
Published: April 2023

Supplementary Table 2 from Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
Supplementary Table S3 from Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma
Authors: Holt Jeremiah , Walter Vonn , Yin Xiaoying , Marron David , Wilkerson Matthew D. , Choi Hyo Young , Zhao Xiaobei , Jo Heejoon , Hayes David Neil , Ko Yoon Ho
Published: April 2023

Summary of functional characteristics of 50 miRNAs based on previously published reports and target gene ontology analysis.
Supplementary Table S2 from Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma
Authors: Holt Jeremiah , Walter Vonn , Yin Xiaoying , Marron David , Wilkerson Matthew D. , Choi Hyo Young , Zhao Xiaobei , Jo Heejoon , Hayes David Neil , Ko Yoon Ho
Published: April 2023

Integrative analysis and unsupervised hierarchical clustering of microRNAs in two patient cohorts.
supplementary figures, from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Authors: Malla Sudhir B. , Fisher David J. , Domingo Enric , Blake Andrew , Hassanieh Sylvana , Redmond Keara L. , Richman Susan D. , Youdell Michael , Walker Steven M. , Logan Gemma E. , Chatzipli Aikaterina , Amirkhah Raheleh , Humphries Matthew P. , Craig Stephanie G. , McDermott Ultan , Seymour Matthew T. , Morton Dion G. , Quirke Philip , West Nicholas P. , Salto-Tellez Manuel , Kennedy Richard D. , Johnston Patrick G. , Tomlinson Ian , Koelzer Viktor H. , Campo Letitia , Kaplan Richard S. , Longley Daniel B. , Lawler Mark , Maughan Timothy S. , Brown Louise C. , Dunne Philip D.
Published: April 2023

Figures S1-S9, Tables S1, S2
Supplementary Data from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Authors: Malla Sudhir B. , Fisher David J. , Domingo Enric , Blake Andrew , Hassanieh Sylvana , Redmond Keara L. , Richman Susan D. , Youdell Michael , Walker Steven M. , Logan Gemma E. , Chatzipli Aikaterina , Amirkhah Raheleh , Humphries Matthew P. , Craig Stephanie G. , McDermott Ultan , Seymour Matthew T. , Morton Dion G. , Quirke Philip , West Nicholas P. , Salto-Tellez Manuel , Kennedy Richard D. , Johnston Patrick G. , Tomlinson Ian , Koelzer Viktor H. , Campo Letitia , Kaplan Richard S. , Longley Daniel B. , Lawler Mark , Maughan Timothy S. , Brown Louise C. , Dunne Philip D.
Published: April 2023

supplementary methods
Supplementary Data Figures from Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis
Authors: Yin Lingdi , Pu Ning , Thompson Elizabeth , Miao Yi , Wolfgang Christopher , Yu Jun
Published: April 2023

Supplementary Data Figures
Supplementary Data Figure Legend from Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis
Authors: Yin Lingdi , Pu Ning , Thompson Elizabeth , Miao Yi , Wolfgang Christopher , Yu Jun
Published: April 2023

Supplementary Data Figure Legend
Table S3 from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
Authors: Adib Elio , Klonowska Katarzyna , Giannikou Krinio , Do Khanh T. , Pruitt-Thompson Solida , Bhushan Ketki , Milstein Matthew I. , Hedglin Jennifer , Kargus Katherine E. , Sholl Lynette M. , Tsuji Junko , Hyman David M. , Sisk Anne , Shapiro Geoffrey I. , Vargas Hebert A. , Harding James J. , Voss Martin H. , Iyer Gopa , Kwiatkowski David J.
Published: April 2023

Table S3. Toxicities (any level) occurring in at least two patients, grouped by CTCAE v4.0 categories. For patients with more than one adverse event per category, only the highest-grade event was counted.
Figure S16 from Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging
Authors: Cheng Nai-Ming , Yao Jiawen , Cai Jinzheng , Ye Xianghua , Zhao Shilin , Zhao Kui , Zhou Wenlan , Nogues Isabella , Huo Yuankai , Liao Chun-Ta , Wang Hung-Ming , Lin Chien-Yu , Lee Li-Yu , Xiao Jing , Lu Le , Zhang Ling , Yen Tzu-Chen
Published: April 2023

Time-dependent ROC analyses, 5-year survival, DeepPET-OPSCC score, clinical factors, nomograms, discovery cohort
Suppl File from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
Authors: Adib Elio , Klonowska Katarzyna , Giannikou Krinio , Do Khanh T. , Pruitt-Thompson Solida , Bhushan Ketki , Milstein Matthew I. , Hedglin Jennifer , Kargus Katherine E. , Sholl Lynette M. , Tsuji Junko , Hyman David M. , Sisk Anne , Shapiro Geoffrey I. , Vargas Hebert A. , Harding James J. , Voss Martin H. , Iyer Gopa , Kwiatkowski David J.
Published: April 2023

Supplementary Methods File
Supplementary Tables S1-S8 from Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
Authors: Tsimberidou Apostolia M. , Beer Philip A. , Cartwright Carrie A. , Haymaker Cara , Vo Henry H. , Kiany Simin , Cecil Alexander R.L. , Dow James , Haque Kemal , Silva Franck A. , Coe Lucy , Berryman Helen , Bone Elisabeth A. , Nogueras-Gonzalez Graciela M. , Vining David , McElwaine-Johnn Hilary , Wistuba Ignacio I.
Published: April 2023

Supplementary Tables
Supplementary figure SF3 from Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer
Authors: Turner Philip G. , Jain Suneil , Cole Aidan , Grey Arthur , Mitchell Darren , Prise Kevin M. , Hounsell Alan R. , McGarry Conor K. , Biggart Sandra , O'Sullivan Joe M.
Published: April 2023

Supplementary figure SF3 shows examples of WB-MRI pre and post 6 cycles of radium-223 and pelvic radiotherapy. A and B showing tumour burden reduction in femora, C and D showing tumour burden reduction in lumbosacral spine and E and F showing tumour burden increase in thoracic spine.
Table S1, Table S2, Table S3 from Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
Authors: Colombo Ilaria , Genta Sofia , Martorana Federica , Guidi Monia , Frattini Milo , Samartzis Eleftherios Pierre , Brandt Simone , Gaggetta Sheila , Moser Laura , Pascale Mariarosa , Terrot Tatiana , Sessa Cristiana , Stathis Anastasios
Published: April 2023

Table S1. All TEAEs at least possibly related to one or more of the study drugs by dose level. Table S2. Statistical summary of the PF-05212384 PK parameters obtained by NCA using the available rich sampling data of cycle 1 after drug administration at day 1. Table S3. Statistical summary of the PF-05212384 PK parameters obtained by NCA using rich sampling data collected until day 4 after drug administration at day 1 cycle 1 and 2.
Supplementary figure SF2 from Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer
Authors: Turner Philip G. , Jain Suneil , Cole Aidan , Grey Arthur , Mitchell Darren , Prise Kevin M. , Hounsell Alan R. , McGarry Conor K. , Biggart Sandra , O'Sullivan Joe M.
Published: April 2023

Supplementary figure SF2 shows mean EPIC score by domain by timepoint. Error bars = 95% confidence intervals.
Figure S4 from A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non–Small Cell Lung Cancer
Authors: Shafique Michael R. , Fisher Terrence L. , Evans Elizabeth E. , Leonard John E. , Pastore Desa Rae E. , Mallow Crystal L. , Smith Ernest , Mishra Vikas , Schröder Andreas , Chin Kevin M. , Beck Joseph T. , Baumgart Megan A. , Govindan Ramaswamy , Gabrail Nashat Y. , Spira Alexander I. , Seetharamu Nagashree , Lou Yanyan , Mansfield Aaron S. , Sanborn Rachel E. , Goldman Jonathan W. , Zauderer Maurice
Published: April 2023

Correlative biomarker analysis: 4A, Shift in balance of tumoral myeloid cells correlates with response. 4B, Baseline circulating AMC and ANC correlate with PFS 4C, High baseline circulating AMC:ALC is associated with disease progression and resistance to immunotherapy 4D, Baseline circulating PMN-MDSC in IOF and ION
Supplementary figure S1 from A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors
Authors: Chida Keigo , Kawazoe Akihito , Kawazu Masahito , Suzuki Toshihiro , Nakamura Yoshiaki , Nakatsura Tetsuya , Kuwata Takeshi , Ueno Toshihide , Kuboki Yasutoshi , Kotani Daisuke , Kojima Takashi , Taniguchi Hiroya , Mano Hiroyuki , Ikeda Masafumi , Shitara Kohei , Endo Itaru , Yoshino Takayuki
Published: April 2023

(A) Kaplan-Meier plots of progression-free survival in the overall population and (B) overall survival in the overall population.
Supplementary Table S6 from A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors
Authors: Chida Keigo , Kawazoe Akihito , Kawazu Masahito , Suzuki Toshihiro , Nakamura Yoshiaki , Nakatsura Tetsuya , Kuwata Takeshi , Ueno Toshihide , Kuboki Yasutoshi , Kotani Daisuke , Kojima Takashi , Taniguchi Hiroya , Mano Hiroyuki , Ikeda Masafumi , Shitara Kohei , Endo Itaru , Yoshino Takayuki
Published: April 2023

Univariate and multivariate analysis of OS according to PTEN mutations and clinical features
Supplementary Table S5 from A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors
Authors: Chida Keigo , Kawazoe Akihito , Kawazu Masahito , Suzuki Toshihiro , Nakamura Yoshiaki , Nakatsura Tetsuya , Kuwata Takeshi , Ueno Toshihide , Kuboki Yasutoshi , Kotani Daisuke , Kojima Takashi , Taniguchi Hiroya , Mano Hiroyuki , Ikeda Masafumi , Shitara Kohei , Endo Itaru , Yoshino Takayuki
Published: April 2023

Univariate and multivariate analysis of PFS according to PTEN mutations and clinical features
Supplementary Table S5 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Authors: Laumont Céline M. , Wouters Maartje C.A. , Smazynski Julian , Gierc Nicole S. , Chavez Elizabeth A. , Chong Lauren C. , Thornton Shelby , Milne Katy , Webb John R. , Steidl Christian , Nelson Brad H.
Published: April 2023

Supplementary Table S5 presents the percentages of expanded vs. non-expanded clonotypes in relevant T-cell subsets.
Supplementary Table S2 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Authors: Laumont Céline M. , Wouters Maartje C.A. , Smazynski Julian , Gierc Nicole S. , Chavez Elizabeth A. , Chong Lauren C. , Thornton Shelby , Milne Katy , Webb John R. , Steidl Christian , Nelson Brad H.
Published: April 2023

Supplementary Table S2 presents relevant information pertaining to the antibodies used in the high-dimensional flow cytometry panel.
Supplementary Data from Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer
Authors: Shi Jie , Wang Zhiyu , Zhang Junping , Xu Yaping , Xiao Xiao , Quan Xiangming , Bai Ying , Yang Xia , Ming Zongjuan , Guo Xiaojin , Feng Huijing , Yang Xiaoling , Zhuang Xiaofei , Han Fei , Wang Kai , Shi Yonglei , Lei Yu , Bai Jun , Yang Shuanying
Published: April 2023

Supplementary Methods
Supplemental Figure 3 from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET
Authors: Nagle Veronica L. , Henry Kelly E. , Hertz Charli Ann J. , Graham Maya S. , Campos Carl , Parada Luis F. , Pandit-Taskar Neeta , Schietinger Andrea , Mellinghoff Ingo K. , Lewis Jason S.
Published: April 2023

Flow Cytometry Gating Strategy. Splenocytes were gated for (1) cells (2-3) single cells (4) live cells (5) mouse CD45 - cells (6) human CD45 + cells (7) human CD3 + cells and (8) human CD8 + cells.
Supplementary Figure 4 from Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer
Authors: Guardia Cristina , Bianchini Giampaolo , Arpí-LLucià Oriol , Menendez Silvia , Casadevall David , Galbardi Barbara , Dugo Matteo , Servitja Sonia , Montero Juan Carlos , Soria-Jiménez Luis , Sabbaghi MohammadA , Peña Raul , Madoz-Gúrpide Juan , Lloveras Belen , Lluch Ana , Eroles Pilar , Arribas Joaquin , Pandiella Atanasio , Gianni Luca , Rojo Federico , Rovira Ana , Albanell Joan
Published: April 2023

Supplementary Figure 4 shows that NRG1 enhances pro-migratory capacity of breast cancer cells as well as the induction of early markers from the EMT process. Moreover, it also shows that trastuzumab plus pertuzumab, but not trastuzumab alone, are able to prevent NRG1-derived effects.
Supplementary Figure 1 from Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer
Authors: Guardia Cristina , Bianchini Giampaolo , Arpí-LLucià Oriol , Menendez Silvia , Casadevall David , Galbardi Barbara , Dugo Matteo , Servitja Sonia , Montero Juan Carlos , Soria-Jiménez Luis , Sabbaghi MohammadA , Peña Raul , Madoz-Gúrpide Juan , Lloveras Belen , Lluch Ana , Eroles Pilar , Arribas Joaquin , Pandiella Atanasio , Gianni Luca , Rojo Federico , Rovira Ana , Albanell Joan
Published: April 2023

Supplementary Figure 1 shows generation and cell-lineage characterization of primary CAF cultures derived from HER2-positive breast cancer patient biopsies. Moreover, it also shows NRG1 staining in two FFPE-associated patient samples from which primary CAFs were derived.
Figure S1 from Non-invasive Detection of Immunotherapy-Induced Adverse Events
Authors: Ferreira Carolina A. , Heidari Pedram , Ataeinia Bahar , Sinevici Nicoleta , Sise Meghan E. , Colvin Robert B. , Wehrenberg-Klee Eric , Mahmood Umar
Published: April 2023

Supplementary Figure S1
Supplementary Figure S3 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
Authors: Veach Darren R. , Storey Claire M. , Lückerath Katharina , Braun Katharina , von Bodman Christian , Lamminmäki Urpo , Kalidindi Teja , Strand Sven-Erik , Strand Joanna , Altai Mohamed , Damoiseaux Robert , Zanzonico Pat , Benabdallah Nadia , Pankov Dmitry , Scher Howard I. , Scardino Peter , Larson Steven M. , Lilja Hans , McDevitt Michael R. , Thorek Daniel L.J. , Ulmert David
Published: April 2023

Supplementary Figure S3. Subcellular localization of hu5A10
Figure S4 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
Authors: Bai Yalai , Cole Kimberly , Martinez-Morilla Sandra , Ahmed Fahad Shabbir , Zugazagoitia Jon , Staaf Johan , Bosch Ana , Ehinger Anna , Nimeus Emma , Hartman Johan , Acs Balazs , Rimm David L.
Published: April 2023

Validation of QuPath TIL algorithms in WTS Sweden set
Figure S1 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
Authors: Bai Yalai , Cole Kimberly , Martinez-Morilla Sandra , Ahmed Fahad Shabbir , Zugazagoitia Jon , Staaf Johan , Bosch Ana , Ehinger Anna , Nimeus Emma , Hartman Johan , Acs Balazs , Rimm David L.
Published: April 2023

Schematic and H&E illustration of breast cancer annotated area and definition of QuPath TIL variables.
Supplementary Methods from BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression
Authors: Warner Evan , Herberts Cameron , Fu Simon , Yip Steven , Wong Amanda , Wang Gang , Ritch Elie , Murtha Andrew J. , Vandekerkhove Gillian , Fonseca Nicolette M. , Angeles Arkhjamil , Beigi Arshia , Schönlau Elena , Beja Kevin , Annala Matti , Khalaf Daniel , Chi Kim N. , Wyatt Alexander W.
Published: April 2023

Supplementary Methods
Table S4 from Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
Authors: Li Dapeng , Chi Yihebali , Chen Xiaohong , Ge Minghua , Zhang Yuan , Guo Zhuming , Wang Jun , Chen Jie , Zhang Jiewu , Cheng Ying , Li Zhendong , Liu Hui , Qin Jianwu , Zhu Jingqiang , Cheng Ruochuan , Xu Zhengang , Zheng Xiangqian , Tang Pingzhang , Gao Ming
Published: April 2023

Quality of life for patients at baseline and the end of 12 treatment cycles evaluated by EORTC QLQ-C30
Table S1 from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer
Authors: Mehrvarz Sarshekeh Amir , Alshenaifi Jumanah , Roszik Jason , Manyam Ganiraju C. , Advani Shailesh M. , Katkhuda Riham , Verma Anuj , Lam Michael , Willis Jason , Shen John Paul , Morris Jeffrey , Davis Jennifer S. , Loree Jonathan M. , Lee Hey Min , Ajani Jaffer A. , Maru Dipen M. , Overman Michael J. , Kopetz Scott
Published: April 2023

Supplementary Table S1
Table S1 from Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
Authors: Li Dapeng , Chi Yihebali , Chen Xiaohong , Ge Minghua , Zhang Yuan , Guo Zhuming , Wang Jun , Chen Jie , Zhang Jiewu , Cheng Ying , Li Zhendong , Liu Hui , Qin Jianwu , Zhu Jingqiang , Cheng Ruochuan , Xu Zhengang , Zheng Xiangqian , Tang Pingzhang , Gao Ming
Published: April 2023

Multivariate analyses of potential prognostic factors for PFS
Figure S4 from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer
Authors: Mehrvarz Sarshekeh Amir , Alshenaifi Jumanah , Roszik Jason , Manyam Ganiraju C. , Advani Shailesh M. , Katkhuda Riham , Verma Anuj , Lam Michael , Willis Jason , Shen John Paul , Morris Jeffrey , Davis Jennifer S. , Loree Jonathan M. , Lee Hey Min , Ajani Jaffer A. , Maru Dipen M. , Overman Michael J. , Kopetz Scott
Published: April 2023

Supplementary Fig S4: Top ten GO enrichment gene sets of ARID1A tumor DEGs demonstrates that most are immune processes related.
Figure S3 from Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
Authors: Li Dapeng , Chi Yihebali , Chen Xiaohong , Ge Minghua , Zhang Yuan , Guo Zhuming , Wang Jun , Chen Jie , Zhang Jiewu , Cheng Ying , Li Zhendong , Liu Hui , Qin Jianwu , Zhu Jingqiang , Cheng Ruochuan , Xu Zhengang , Zheng Xiangqian , Tang Pingzhang , Gao Ming
Published: April 2023

Mean scores (Standard Deviation) of quality of life (QoL) evaluated at different time point of assessment
Figure S1 from Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
Authors: Li Dapeng , Chi Yihebali , Chen Xiaohong , Ge Minghua , Zhang Yuan , Guo Zhuming , Wang Jun , Chen Jie , Zhang Jiewu , Cheng Ying , Li Zhendong , Liu Hui , Qin Jianwu , Zhu Jingqiang , Cheng Ruochuan , Xu Zhengang , Zheng Xiangqian , Tang Pingzhang , Gao Ming
Published: April 2023

Subgroup analysis of progression-free survival (PFS) and hazard ratios according to baseline characteristics
Supplementary Table 2 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases
Authors: Smalley Inna , Chen Zhihua , Phadke Manali , Li Jiannong , Yu Xiaoqing , Wyatt Clayton , Evernden Brittany , Messina Jane L. , Sarnaik Amod , Sondak Vernon K. , Zhang Chaomei , Law Vincent , Tran Nam , Etame Arnold , Macaulay Robert J.B. , Eroglu Zeynep , Forsyth Peter A. , Rodriguez Paulo C. , Chen Y. Ann , Smalley Keiran S.M.
Published: April 2023

Supplemental Table 2: Sample and Patient Clinical Correlative Information
TRIPOD Checklist from Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
Authors: Zaccaria Gian Maria , Bertamini Luca , Petrucci Maria Teresa , Offidani Massimo , Corradini Paolo , Capra Andrea , Romano Alessandra , Liberati Anna Marina , Mannina Donato , de Fabritiis Paolo , Cascavilla Nicola , Ruggeri Marina , Mina Roberto , Patriarca Francesca , Benevolo Giulia , Belotti Angelo , Gaidano Gianluca , Nagler Arnon , Hájek Roman , Spencer Andrew , Sonneveld Pieter , Musto Pellegrino , Boccadoro Mario , Gay Francesca
Published: April 2023

TRIPOD Checklist. Prediction Model Development
Supplementary Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
Authors: Yam Clinton , Yen Er-Yen , Chang Jeffrey T. , Bassett Roland L. , Alatrash Gheath , Garber Haven , Huo Lei , Yang Fei , Philips Anne V. , Ding Qing-Qing , Lim Bora , Ueno Naoto T. , Kannan Kasthuri , Sun Xiangjie , Sun Baohua , Parra Cuentas Edwin Roger , Symmans William Fraser , White Jason B. , Ravenberg Elizabeth , Seth Sahil , Guerriero Jennifer L. , Rauch Gaiane M. , Damodaran Senthil , Litton Jennifer K. , Wargo Jennifer A. , Hortobagyi Gabriel N. , Futreal Andrew , Wistuba Ignacio I. , Sun Ryan , Moulder Stacy L. , Mittendorf Elizabeth A.
Published: April 2023

Supplementary Tables S1-5 and Supplementary Fig. S1
Supplementary Figure S6 from Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
Authors: Zaccaria Gian Maria , Bertamini Luca , Petrucci Maria Teresa , Offidani Massimo , Corradini Paolo , Capra Andrea , Romano Alessandra , Liberati Anna Marina , Mannina Donato , de Fabritiis Paolo , Cascavilla Nicola , Ruggeri Marina , Mina Roberto , Patriarca Francesca , Benevolo Giulia , Belotti Angelo , Gaidano Gianluca , Nagler Arnon , Hájek Roman , Spencer Andrew , Sonneveld Pieter , Musto Pellegrino , Boccadoro Mario , Gay Francesca
Published: April 2023

Figure S6. OS of ASCT-eligible (A) and ASCT-ineligible (B) patients according to S-ERMM score
Supplementary Data from Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study
Authors: Jacobs Samuel A. , Lee James J. , George Thomas J. , Wade James L. , Stella Philip J. , Wang Ding , Sama Ashwin R. , Piette Fanny , Pogue-Geile Katherine L. , Kim Rim S. , Gavin Patrick G. , Lipchik Corey , Feng Huichen , Wang Ying , Finnigan Melanie , Kiesel Brian F. , Beumer Jan H. , Wolmark Norman , Lucas Peter C. , Allegra Carmen J. , Srinivasan Ashok
Published: April 2023

Supp Table 1
Supplementary Method from Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations
Authors: Karpinets Tatiana V. , Mitani Yoshitsugu , Liu Bin , Zhang Jianhua , Pytynia Kristen B. , Sellen Linton D. , Karagiannis Danice T. , Ferrarotto Renata , Futreal Andrew P. , El-Naggar Adel K.
Published: April 2023

Brief description of the sequencing approach and data processing.
Figure S3 from Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study
Authors: Jacobs Samuel A. , Lee James J. , George Thomas J. , Wade James L. , Stella Philip J. , Wang Ding , Sama Ashwin R. , Piette Fanny , Pogue-Geile Katherine L. , Kim Rim S. , Gavin Patrick G. , Lipchik Corey , Feng Huichen , Wang Ying , Finnigan Melanie , Kiesel Brian F. , Beumer Jan H. , Wolmark Norman , Lucas Peter C. , Allegra Carmen J. , Srinivasan Ashok
Published: April 2023

Figure SF3 Comparisons of the expression of the NRG family of ERBB ligands, at the RNA level, between post-anti-EGFR metastatic biopsies collected upon enrollment into FC-7, and post-neratinib residual tumor tissue samples.
Supplementary Table from Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer
Authors: Sztupinszki Zsofia , Diossy Miklos , Borcsok Judit , Prosz Aurel , Cornelius Nanna , Kjeldsen Maj K. , Mirza Mansoor R. , Szallasi Zoltan
Published: April 2023

Supplementary Table
Supplementary Data from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma
Authors: Tuscano Joseph M. , Poh Christina , Kaesberg Paul , Luxardi Guilluame , Merleev Alexander , Marusina Alina , Brunson Ann , Rosenberg Aaron , Jonas Brian , Maverakis Emanual
Published: April 2023

Supplemental Table 1
Supplementary Figure S5 from Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer
Authors: Sztupinszki Zsofia , Diossy Miklos , Borcsok Judit , Prosz Aurel , Cornelius Nanna , Kjeldsen Maj K. , Mirza Mansoor R. , Szallasi Zoltan
Published: April 2023

Doublet Base Substitution Signatures, TCGA WES cohort
Supplementary Figure S4 from Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer
Authors: Sztupinszki Zsofia , Diossy Miklos , Borcsok Judit , Prosz Aurel , Cornelius Nanna , Kjeldsen Maj K. , Mirza Mansoor R. , Szallasi Zoltan
Published: April 2023

Single nucleotide mutational signatures - COSMICv3, TCGA WES cohort
Supplementary Table 2 from Spatially Distinct Reprogramming of the Tumor Microenvironment Based On Tumor Invasion in Diffuse-Type Gastric Cancers
Authors: Jeong Hye Young , Ham In-Hye , Lee Sung Hak , Ryu Daeun , Son Sang-Yong , Han Sang-Uk , Kim Tae-Min , Hur Hoon
Published: April 2023

Sample Information